Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study

ClinicalTrials.gov ID: NCT06033833

Public ClinicalTrials.gov record NCT06033833. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 1:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Long-term Extension Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study

Study identification

NCT ID
NCT06033833
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sanofi
Industry
Enrollment
335 participants

Conditions and interventions

Conditions

Interventions

  • Amlitelimab Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 4, 2023
Primary completion
Sep 28, 2026
Completion
Sep 28, 2026
Last update posted
May 19, 2026

2023 – 2026

United States locations

U.S. sites
8
U.S. states
6
U.S. cities
8
Facility City State ZIP Site status
Bensch Research Associates- Site Number : 8400004 Stockton California 95207
Helix Biomedics- Site Number : 8400029 Boynton Beach Florida 33435
Savin Medical Group - Miami Lakes- Site Number : 8400015 Miami Lakes Florida 33014
Pines Care Research Center- Site Number : 8400028 Pembroke Pines Florida 33025
Treasure Valley Medical Research- Site Number : 8400031 Boise Idaho 83706
Johns Hopkins Bayview Medical Center- Site Number : 8400012 Baltimore Maryland 21224
OK Clinical Research- Site Number : 8400001 Edmond Oklahoma 73034
South Texas Medical Research Institute - TTS Research- Site Number : 8400011 Boerne Texas 78006

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 60 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06033833, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 19, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06033833 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →